Astellas stops developing autologous cell therapy for lymphomanews2025-01-08T18:14:37+00:00January 8th, 2025|Endpoints News|
Roche’s Chugai partners with Swiss ADC biotech Ararisnews2025-01-08T13:00:51+00:00January 8th, 2025|Endpoints News|
Aetna takes Takeda to court over ‘anticompetitive scheme’ with generic drugsnews2025-01-07T20:01:45+00:00January 7th, 2025|Endpoints News|
Drugmakers cut list prices for some cancer, asthma and diabetes treatmentsnews2025-01-07T19:22:48+00:00January 7th, 2025|Endpoints News|
BWX Technologies to buy Canadian isotope maker for $525Mnews2025-01-07T16:30:28+00:00January 7th, 2025|Endpoints News|
J&J’s combo beats Tagrisso on survival in first-line lung cancernews2025-01-07T13:00:35+00:00January 7th, 2025|Endpoints News|
FDA drug approvals 2024: Rare diseases, schizophrenia and Alzheimer’snews2025-01-06T15:00:39+00:00January 6th, 2025|Endpoints News|
Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofinews2025-01-03T19:28:08+00:00January 3rd, 2025|Endpoints News|
Eli Lilly seeks to join lawsuit over end of tirzepatide shortagenews2025-01-03T18:08:24+00:00January 3rd, 2025|Endpoints News|
Novo petitions FDA over Victoza compounding as first generic wins approvalnews2025-01-03T18:06:06+00:00January 3rd, 2025|Endpoints News|
